Skip to main content

Intensive Immunosuppression with Cyclophosphamide in Remittent Forms of Multiple Sclerosis. A Follow-Up of 134 Patients for 2–10 Years

  • Conference paper
Progress in Multiple Sclerosis Research

Abstract

Since 1968, immunosuppression with cyclophosphamide has been applied in 201 MS cases experiencing frequent relapses and hospitalized in the Belgian Center for Multiple Sclerosis (MS).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aimard G, Girard PF, Raveau J (1966) Sclérose en plaques et processus d’auto-immunisation. Traitement par les antimitotiques. Lyon Med 6:345–352

    Google Scholar 

  2. Cendrowski WS (1973) Combined therapeutic trial in multiple sclerosis: hydrocortisone hemisuccinate with cyclophosphamide or cytosine arabinoside. Acta Neurol Belg 73:209–219

    PubMed  CAS  Google Scholar 

  3. Delmotte P (1977) Analysis of complex protein mixtures by capillary isotachophoresis. Some qualitative and quantitative aspects. Sci Tools 24:33–41

    Google Scholar 

  4. Drachman DA, Paterson PY, Schmidt RT, Spehlmann RF (1975) Cyclophosphamide in exacerbations of multiple sclerosis. Therapeutic trial and a strategy for pilot drug studies. J Neurol Neurosurg Psychiatry 38:592–597

    Article  PubMed  CAS  Google Scholar 

  5. Gantol K, Laurell CB (1974) Measurement of IgG and albumine content of CSF and its interpretation. Clin Chem 20:571–573

    Google Scholar 

  6. Girard PF, Aimard G, Pellet H (1967 Les immuno-dépresseurs. Thérapeutique immuno-dépressive en neurologie. La Presse Medicale 75:967–968

    PubMed  CAS  Google Scholar 

  7. Gonsette RE, Demonty L, Delmotte P (1977) Intensive immunosuppression with cyclophosphamide in multiple sclerosis. J Neurol 214:173–181

    Article  PubMed  CAS  Google Scholar 

  8. Gonsette RE, Demonty L, Delmotte P (1978) Failure of basic protein therapy in multiple sclerosis. J Neurol 216:27–31

    Article  Google Scholar 

  9. Hommes OR, Prick JJG, Lamers KJB (1975) Treatment of the chronic progressive form of multiple sclerosis with a combination of cyclophosphamide and Prednisone. Clin Neurol Neurosurg 78:59–72

    Article  PubMed  CAS  Google Scholar 

  10. Lamers KJB, Hommes OR, Kok JCN (1977) Cerebrospinal fluid IgG in multiple sclerosis patients during and after intensive immunsuppressive treatment. In: Delmotte, Hommes OR, Gonsette R (eds) Immunosuppressive treatment in multiple sclerosis. European Press, Gent, pp 182–194

    Google Scholar 

  11. Lhermitte F, Marteau R, Gazengel J, Dordain G, Deloche G (1973) The frequency of relapse in multiple sclerosis. Z Neurol 205:47–59

    Article  PubMed  CAS  Google Scholar 

  12. Millac P, Miller H (1969) Cyclophosphamide in multiple sclerosis. Lancet II:783

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1980 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Gonsette, R.E., Demonty, L., Delmotte, P. (1980). Intensive Immunosuppression with Cyclophosphamide in Remittent Forms of Multiple Sclerosis. A Follow-Up of 134 Patients for 2–10 Years. In: Bauer, H.J., Poser, S., Ritter, G. (eds) Progress in Multiple Sclerosis Research. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67554-6_74

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-67554-6_74

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-67556-0

  • Online ISBN: 978-3-642-67554-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics